Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Narula

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Gastroenterology|October 11, 2016
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel DiseasesJean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet
Gut|June 7, 2022
Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Gui <i>et al</i>Emily C L Wong, Parambir S Dulai, Neeraj Narula
The American Journal of Medicine|July 31, 2012
Are patients with inflammatory bowel disease at increased risk of coronary artery disease?Sumeet Gandhi, Neeraj Narula, John K Marshall, et al.
Inflammatory Bowel Diseases|February 8, 2023
Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysisMichael Youssef, Kelly Dong, So Jeong Lee, et al.
Inflammatory Bowel Diseases|April 4, 2017
Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011Neeraj Narula, Lawrence Borges, A Hillary Steinhart, et al.
Journal of Crohn'S & Colitis|August 24, 2022
Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical ResearchNeeraj Narula, Shahin Merat, David Liu, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 28, 2023
Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort studyAbdulaziz Saad Alshahrani, Danah Mohammad, Mohammad Attieh Alzahrani, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 21, 2012
An audit of influenza vaccination status in adults with inflammatory bowel diseaseNeeraj Narula, Amit S Dhillon, Usha Chauhan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2016
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysisShailja C Shah, Jean-Frederic Colombel, Bruce E Sands, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2016
ReplyShailja C Shah, Jean-Frederic Colombel, Bruce E Sands, et al.
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Gastroenterology|October 11, 2016
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel DiseasesJean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet
Gut|June 7, 2022
Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Gui <i>et al</i>Emily C L Wong, Parambir S Dulai, Neeraj Narula
The American Journal of Medicine|July 31, 2012
Are patients with inflammatory bowel disease at increased risk of coronary artery disease?Sumeet Gandhi, Neeraj Narula, John K Marshall, et al.
Inflammatory Bowel Diseases|February 8, 2023
Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysisMichael Youssef, Kelly Dong, So Jeong Lee, et al.
Inflammatory Bowel Diseases|April 4, 2017
Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011Neeraj Narula, Lawrence Borges, A Hillary Steinhart, et al.
Journal of Crohn'S & Colitis|August 24, 2022
Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical ResearchNeeraj Narula, Shahin Merat, David Liu, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 28, 2023
Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort studyAbdulaziz Saad Alshahrani, Danah Mohammad, Mohammad Attieh Alzahrani, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 21, 2012
An audit of influenza vaccination status in adults with inflammatory bowel diseaseNeeraj Narula, Amit S Dhillon, Usha Chauhan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2016
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysisShailja C Shah, Jean-Frederic Colombel, Bruce E Sands, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2016
ReplyShailja C Shah, Jean-Frederic Colombel, Bruce E Sands, et al.
Pageof 21